Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 11
Submit an article Journal homepage
48
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Veno-occlusive Disease of the Liver after Blood and Marrow Transplantation: Analysis of Pre- and Post-transplant Risk Factors Associated with Severity and Results of Therapy with Tissue Plasminogen Activator

Mark R. Litzow Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
,
Panagiotis D. Repoussis Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
,
Georgene Schroeder Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
,
David Schembri-Wismayer Blackburn Royal Infirmary, Blackburn BB2 3LR, UK
,
Kenneth P. Batts Department of Laboratory Medicine and Pathology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
,
Peter M. Anderson Section of Pediatric Hematology/Oncology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
,
Carola A.S. Arndt Section of Pediatric Hematology/Oncology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
,
Michael G. Chen Division of Radiation Oncology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
,
Dennis A. Gastineau Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
,
Morie A. Gertz Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
,
David J. Inwards Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
,
Martha Q. Lacy Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
,
Ayalew Tefferi Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
,
Pierre Noël Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ, USA
,
Lawrence A. Solberg Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA
,
Louis Letendre Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
&
H. Clark Hoagland Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
 show all
Pages 2099-2107 | Published online: 01 Jul 2009

  • McDonald, G.B., Hinds, M.S., Fisher, L.D., Schoch, H G., Wolford. J.L., Banaji, M., Hardin, B.J., Shulman, H.M. and CIift, R.A. (1993) "Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation; a cohort study of 355 patients", Annals of Internal Medicine 118, 255-267.
  • McDonald, G.B., Sharma, P., Matthews, D.E., Shulman, H.M. and Thomas, E.D. (1984) "Venocclusive disease of the liver after bone marrow transplantation, diagnosis, incidence, and predisposing factors", Hepatology 4, 116-122.
  • Hasegawa, S., Horibe, K., Kawabe, T., Kalo, K., Kojima, S., Matsuyama, T. and Hirabayashi, N. (1998) "Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors", Bone Marrow Transplantation 22, 1191-1197.
  • Ton, H.C., McAfee, S.L., Sackstcin, R., Cox. B.F., Colby, C. and Spitzer, T.R. (1999) "Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation", Bone Marrow Transplantation 24, 891-895.
  • Bearman, S.I. (1995) "The syndrome of hepatic veno-occlusive disease after marrow transplantation", Blood 85, 3005-3020.
  • Shulman, H.M., McDonald, G.B., Matthews, D., Doney, K.C., Kopecky, K.J., Gauvreau, J.M. and Thomas, E.D. (1980) "An analysis of hepatic venocclusivc disease and centrilobular hepatic degeneration following bone marrow transplantation", Gastroenterology 79, 1178-1191.
  • Jones, R.J., Lee, K.S., Beschorner, W.E., Vogel, V.G., Grochow, L.B., Braine, H.G., Vogelsang, G.B., Sensenbrenner, L.L., Santos, G.W. and Saral, R. (1987) "Veno-occlusive disease of the liver following bone marrow transplantation", Transplantation 44, 778-783.
  • Blostein, M.D., Paltiel, O.B., Thibault, A. and Rybka, W.B. (1992) "A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation", Bone Marrow Transplantation 10, 439-443.
  • Shulman, H.M. and Hinterberger, W. (1992) "Hepatic venoocclusive disease--liver toxicity syndrome after bone marrow transplantation", Bane Marrow Transplantation 10, 197-214.
  • Baglin, T.P., Harper, P. and Marcus, R.E. (1990) "Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA)", Bone Marrow Transplantation 5, 439-441.
  • Bearman, S.I., Shuhart, M.C., Hinds, M.S. and McDonald, G.B. (1992) "Recombinant human tissue plasminogen activator for the treatment of established severe veno-occlasive disease of the liver after bone marrow transplantation", Blood 80, 2458-2462.
  • Ringden, O., Wennberg, L., Ericzon, B.C., Kallman, R., Astrom, M., Duraj, E. Soderdahl, G., Tyden, G. and Groth, C.G. (1992) "Alteplase for hepatic veno-occlusive disease after bone marrow transplantation" (letter). Lancet 340, 546-547.
  • Rosti, G., Bandini, G., Belardinelli, A., Calori, E., Tura, S., Gherliozoui, F. and Miggiano, C. (1992) "Alteplase for hepatic veno-occlusive disease after bone-marrow transplantation" (letter). Lancet 339, 1481-1482.
  • Espigado, I., Rodriguez, J.M., Parody, R., Carmona, M., Digon, J. and Olloqui, E. (1995) "Reversal of severe hepatic veno-occlusive disease by combined plasma exchange and ri-PA treatment", Bone Morrow Transplantation 16, 313-316.
  • Hagglund, H., Ringden, O., Ljungman, P., Winiarski, J., Ericzon, B. and Tyden, G. (1995) "No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogcneic bone marrow transplantation", Transplantation Proceedings 27, 3535.
  • Goldberg, S.L., Shubert, J., Rao, A.K., Redei, I., Klumpp, T.R. and Mangan, K.F. (1996) 'Treatment of hepatic veno-occlusive disease with low-dose tissue plamninogeo activator impact on coagulation profile". Bone Marrow Transplantation 18, 633-636.
  • Leahey, A.M. and Bunin, N.J. (1996) "Recombinant human tissue plasminogen activator for the treatment of severe hepatic venoocclusive disease in pediatric bone marrow transplant patients", Bone Marrow Transplantation 17, 1101-1104.
  • Kulkarni, S., Rodriguez, M., Lifuente, A., Mateos, P., Mehta, J., Singhal, S., Saso, R., Tait, D., Treleaven, J.G. and Powles, R.L. (1999) "Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD)", Bone Marrow Transplantation 23, 803-807.
  • Ganem, G., Saint-Marc Girardin, M.F., Kuentz, M., Cordonnier, C., Marinello, G., Teboul, C., Braconnier, F., Vernant, J.P., Dhumeaux, D. and Le Bourgeois, J.P. (1988) "Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in man", International Journal of Radiation Oncology, Biology, Physics 14, 879-884
  • Essell, J.H., Thompson, J.M., Haraian, G.S., Halvorson, R.D., Snyder, M.J., Johnson, R.A. and RubinsaK, J.R. (1992) "Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide", Blood 79, 2784-2788.
  • Carreras, E., Bertz, H., Areese, W., Vernant, J.R, Tomas, J.F., Hagglund, H., Bandini, G., Esperou, H., Russell, J., de la Rubia, J., Di Girolamo, G., Demuynck, H., Hartmann, O., Clausen, J., Ruutu, T., Leblond, V., Iriondo, A., Bosi, A., Ben-Bassat, I., Koza, V., Gratwohl, A. and Apperley, J.F. (1998) "Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation, European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party", Blood 92, 3599-3604.
  • Rozman, C., Carreras, E., Qian, C., Gale, R.P., Bortin, M.M., Rowlings, P.A., Ash, R.C., Champlin, R.E., Henslee-Downey, P.J., Herzig, R.H., Hinterberger, W., Klein, J.P., Prentice, H.G., Reiffers, J. Zwaan, F.E. and Horowilz, M.M. (1996) "Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone morrow transplants for leukemia", Bone Marrow Tyansptantation 17, 75-80.
  • Hagglund, H., Remberger, M., Klaesson, S., Lonnqvist, B., Ljungman, P. and Ringden, O. (1998) "Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation", Blood 92, 4568-4572.
  • Bearman, S.I., Andersen, G.L., Mon, M., Hinds, M.S., Shulman, H.M. and McDonald, GB. (1993) "Veno-occlusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation", Journal of Clinical Oncology 11, 1729-1736.
  • Terra, S.G., Spitzer, T.R. and Tsunoda, S.M. (1997) "A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantation", Pharmacotherapy 17, 929-937.
  • Bearman, S.I., Lee, J.L., Baron, A.E. and McDonald, G.B. (1997) "Treatment of hepatic veno-occlusive disease with recombinant human tissue plasminogen activator and heparin in 42 morrow transplant patients", Blood 89, 1501-1506.
  • Schriber, J., Milk, B., Shaw, D., Christiansen, N., Baer, M., Slack, J., Tezcan, H., Wetzler, M. and Herzig, G. (1999) 'Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation", Bone Marrow Transplantation 24, 1311-1314.
  • Richardson, P.G., Elias, A.D., Krishnan, A., Wheeler, C. Nath, R., Hoppensteadt, D., Kinchla, N.M., Neuberg, D., Waller, E.K., Antin, J.H., Soiffer, R., Vredenburgh, J., LiIl, M., Woolfrey, A.E., Bearman, S.I., Iacobelli, M., Fareed, J. and Guinan, E.C. (1998) "Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population", Blood 92, 737-744.
  • Chopra, R., Eaton, I.D., Grassi, A., Potter, M., Shaw, B., Salat, C., Neumeister, P., Finazzi, G., Iacobelli, M., Bowyer, K., Prentice, H.G. and Barbui, T. (2000) "Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European Compassionate-Use Study", British Journal of Haematology 111, 1122-1129.
  • Khoury, H., Adkins, D., Brown, R., Trinkaus, K., Vij, R., Miller, G., Goodnough, L.T. and DiPersio, J. (2000) "Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?", Bone Marrow Transplantation 25, 737-743.
  • Ringden, O., Remberger, M., Lehmann, S., Hentschke, P., Maltsson, J., Klaesson, S. and Aschin, J. (2000) "N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation", Bone Marrow Transplantation 25, 993- 996.
  • Richardson, P. and Guinan, E. (1999) "The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: current status and novel approaches", British Journal of Haematology 107, 485-493.
  • Azoulay, D., Castaing, D., Lemoine, A., Hargreaves, G.M. and Bismuth, H. (2000) "Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation", Bone Marrow Transplantation 25, 987-992.
  • Or, R., Nagler, A., Shpilberg, O., Elad, S., Naparstek, E., Kapelushiuk, J., Cass, Y., Gillis, S., Chetrit, A., Slavin, S. and Eldor, A. (1996) "Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients", Transplantation 61, 1067-1071.
  • Essell, J.H., Schroeder, M.T., Herman, G.S., Halvorson, R., Lew, V., Callander, N., Snyder, M., Lewis, S.K., Allerton, J.P. and Thompson, J.M. (1998) "Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation A randomized, double-blind, placebo-controlled trial", Annals of Internal Medicine 128, 975-981.
  • Ohashi, K., Tanabe, J., Watanabe, R., Tanaka, T., Sakamaki, H., Maruta, A., Okamoto, S., Aotsuka, N., Saito, K., Nishimura, M., Oh, H., Matsuzaki, M., Takahashi, S. and Yonekura, S. (2000) "The Japanese multicenter open randomized trial of ursodeoxycnolic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation", American Journal of Hemalology 64, 32-38.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.